Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ERGONASDAQ:GRINASDAQ:HCMTSE:ITH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeERGOEntia Biosciences$0.00$0.00▼$0.00N/A12.3150 shsN/AGRIGRI Bio$1.82+9.0%$4.54$1.10▼$106.04$877K-1.72281,127 shs241,291 shsHCMHUTCHMED$14.61-7.2%$14.96$11.51▼$21.92$2.55B0.66106,644 shs162,194 shsITHInternational Tower Hill MinesC$0.87-5.4%C$0.85C$0.57▼C$1.10C$122.15M1.1728,937 shs22,500 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceERGOEntia Biosciences0.00%0.00%0.00%0.00%0.00%GRIGRI Bio0.00%+20.53%-68.99%-82.59%-98.12%HCMHUTCHMED0.00%+6.18%-4.26%+7.74%-20.64%ITHInternational Tower Hill Mines0.00%-4.40%-8.42%+22.54%+1.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationERGOEntia BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AGRIGRI Bio2.3418 of 5 stars3.52.00.00.03.30.01.3HCMHUTCHMED1.8979 of 5 stars3.02.00.00.01.80.01.9ITHInternational Tower Hill MinesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceERGOEntia Biosciences 0.00N/AN/AN/AGRIGRI Bio 3.00Buy$115.506,246.15% UpsideHCMHUTCHMED 2.00Hold$19.0030.05% UpsideITHInternational Tower Hill Mines 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ERGO, ITH, HCM, and GRI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/14/2025GRIGRI BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00(Data available from 4/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookERGOEntia BiosciencesN/AN/AN/AN/AN/AN/AGRIGRI BioN/AN/AN/AN/A$5.22 per shareN/AHCMHUTCHMED$630.20M4.04$0.60 per share24.51$4.27 per share3.42ITHInternational Tower Hill MinesN/AN/AC$0.04 per share22.50C$0.29 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateERGOEntia BiosciencesN/AN/A0.00N/AN/AN/AN/AN/AN/AGRIGRI Bio-$13.04M-$11.56N/AN/AN/AN/A-289.05%-165.01%5/9/2025 (Estimated)HCMHUTCHMED$100.78MN/A0.0010.01N/AN/AN/AN/A5/9/2025 (Estimated)ITHInternational Tower Hill Mines-C$2.36M-C$0.02N/A∞N/AN/A-5.82%-3.65%N/ALatest ERGO, ITH, HCM, and GRI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025N/AGRIGRI Bio-$4.08N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthERGOEntia BiosciencesN/AN/AN/AN/AN/AGRIGRI Bio$1.91104.95%N/AN/A N/AHCMHUTCHMEDN/AN/AN/AN/AN/AITHInternational Tower Hill MinesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioERGOEntia BiosciencesN/AN/AN/AGRIGRI BioN/A3.103.10HCMHUTCHMED0.072.812.68ITHInternational Tower Hill MinesN/A10.3730.48Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipERGOEntia BiosciencesN/AGRIGRI Bio33.95%HCMHUTCHMED8.82%ITHInternational Tower Hill Mines71.80%Insider OwnershipCompanyInsider OwnershipERGOEntia Biosciences28.30%GRIGRI Bio0.13%HCMHUTCHMED3.60%ITHInternational Tower Hill Mines0.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableERGOEntia Biosciences6N/AN/ANot OptionableGRIGRI Bio1525,0008.92 millionNot OptionableHCMHUTCHMED1,760174.32 million168.04 millionNot OptionableITHInternational Tower Hill Mines220140.40 millionN/ANot OptionableERGO, ITH, HCM, and GRI HeadlinesRecent News About These CompaniesTrump signs order seeking to jump-start mining of the ocean floorApril 25 at 1:02 PM | msn.comInternational mining giant dropping out of partnership in Alaska gold mining projectApril 24 at 6:13 AM | alaskabeacon.comInternational Tower Hill Mines (TSE:ITH) Shares Pass Above 50 Day Moving Average - What's Next?April 20, 2025 | marketbeat.comInternational Tower Hill Mines (TSE:ITH) Stock Price Passes Below 50 Day Moving Average - Here's WhyApril 12, 2025 | marketbeat.comWhy International Tower Hill Mines Ltd.’s (THM) Stock Is Up 8.29%April 12, 2025 | aaii.comInternational Tower Hill Mines (TSE:ITH) Stock Crosses Above 50-Day Moving Average - Time to Sell?April 3, 2025 | marketbeat.comInternational Tower Hill Mines Approves 2025 Livengood Gold Project Work Plan and Files 2024 Year End Financial ResultsMarch 12, 2025 | ca.finance.yahoo.comInternational Tower Hill Mines announces $3.9M non-brokered private placementMarch 4, 2025 | markets.businessinsider.com7 Most Obscure Towns In America You Wouldn't Think To VisitNovember 7, 2024 | msn.comHedge funds investors control 32% of International Tower Hill Mines Ltd. (TSE:ITH) and were rewarded last week after stock increased 44%October 17, 2024 | finance.yahoo.comJust Over the Border from Israel, a Hezbollah Cache of Explosives and MinesOctober 14, 2024 | nytimes.comPrince Harry Is Keeping Princess Diana's Landmine Legacy Alive: 'He Wants to Finish the Job' (Exclusive)September 29, 2024 | people.comDozens of Massachusetts lawmakers tell RMV to hit the brakes on revoking CDLsSeptember 27, 2024 | ca.news.yahoo.comAfter personal appeal from Zelensky, Trump agrees to meet with the Ukrainian president after allSeptember 27, 2024 | washingtonexaminer.com8 Theme Parks That Go All Out for Halloween and ChristmasSeptember 25, 2024 | msn.comElection 2024 live updates: Trump returns to N.C.; Harris delivering economic address in Pa.September 25, 2024 | msn.comIran believes all remaining workers have died in coal mine explosion, raising death toll to 49September 24, 2024 | thehill.comIran methane leak causes coal mine explosion, killing at least 30September 22, 2024 | msn.comAt least 19 killed as methane leak causes explosion at eastern Iran coal mine, state TV reportsSeptember 22, 2024 | abcnews.go.com'LOCASH Golf Bash' on HHI benefits Tunnels to Tower FoundationSeptember 21, 2024 | msn.comBUSINESS AND PHILANTHROPIC LEADERS UNITE TO RAISE $300M FOR UHN'S NEW SURGICAL TOWERSeptember 14, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Stocks Near 52-Week Lows With Strong Rebound PotentialBy Gabriel Osorio-Mazilli | March 31, 2025View 3 Stocks Near 52-Week Lows With Strong Rebound Potential4 Healthcare Stocks With Massive Gains—and More to ComeBy Sarah Horvath | March 29, 2025View 4 Healthcare Stocks With Massive Gains—and More to ComeTop 2 Stocks to Ride the AI Boom Without NVIDIABy Jea Yu | April 7, 2025View Top 2 Stocks to Ride the AI Boom Without NVIDIAWhy NVIDIA Stock Could Soar Despite Wall Street DowngradesBy Thomas Hughes | April 14, 2025View Why NVIDIA Stock Could Soar Despite Wall Street DowngradesTesla Stock Eyes Breakout With Earnings on DeckBy Sam Quirke | April 16, 2025View Tesla Stock Eyes Breakout With Earnings on DeckERGO, ITH, HCM, and GRI Company DescriptionsEntia Biosciences OTCMKTS:ERGOEntia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.GRI Bio NASDAQ:GRI$1.82 +0.15 (+8.98%) As of 04/25/2025 04:00 PM EasternGRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.HUTCHMED NASDAQ:HCM$14.61 -1.13 (-7.18%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$14.70 +0.09 (+0.62%) As of 04/25/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.International Tower Hill Mines TSE:ITHC$0.87 -0.05 (-5.43%) As of 04/25/2025 03:49 PM EasternInternational Tower Hill Mines Ltd. engages in the acquisition, exploration, and development of mineral properties. It holds rights to acquire interests in the Livengood gold project covering an area of approximately 19,546 hectares located to the northwest of Fairbanks, Alaska. The company was formerly known as Tower Hill Mines Ltd. and changed its name to International Tower Hill Mines Ltd. in March 1991. International Tower Hill Mines Ltd. was incorporated in 1978 and is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
